Evidence map›Paper›PMID 33411494›Full record

ArticleAccounts of chemical research2021

Metamorphoses of Cesium Lead Halide Nanocrystals.

Stefano Toso, Dmitry Baranov, Liberato Manna

Open access · hybridAbstract read
In one paragraph

Article in Accounts of chemical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 56 citations in OpenAlex.

  1. Next-generation CsPbBrRSC advances · 2026
    Review
  2. Article
  3. Article
  4. CsPbClJournal of the American Chemical Society · 2023
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Stefano TosoDepartment of Nanochemistry, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.
Dmitry BaranovDepartment of Nanochemistry, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.ORCID 0000-0001-6439-8132
Liberato MannaDepartment of Nanochemistry, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.ORCID 0000-0003-4386-7985
Italian Institute of Technology · ITUniversità Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the impressive development of bulk lead-based perovskite photovoltaics, the "perovskite fever" did not spare nanochemistry. In just a few years, colloidal cesium lead halide perovskite nanocrystals have conquered researchers worldwide with their easy synthesis and color-pure photoluminescence. These nanomaterials promise cheap solution-processed lasers, scintillators, and light-emitting diodes of record brightness and efficiency. However, that promise is threatened by poor stability and unwanted reactivity issues, throwing down the gauntlet to chemists.More generally, Cs-Pb-X nanocrystals have opened an exciting chapter in the chemistry of colloidal nanocrystals, because their ionic nature and broad diversity have challenged many paradigms established by nanocrystals of long-studied metal chalcogenides, pnictides, and oxides. The chemistry of colloidal Cs-Pb-X nanocrystals is synonymous with change: these materials demonstrate an intricate pattern of shapes and compositions and readily transform under physical stimuli or the action of chemical agents. In this Account, we walk through four types of Cs-Pb-X nanocrystal metamorphoses: change of structure, color, shape, and surface. These transformations are often interconnected; for example, a change in shape may also entail a change of color.The ionic bonding, high anion mobility due to vacancies, and preservation of cationic substructure in the Cs-Pb-X compounds enable fast anion exchange reactions, allowing the precise control of the halide composition of nanocrystals of perovskites and related compounds (e.g., CsPbCl

Identifiers

PMID33411494
PMCPMC7880526
OpenAlexW3119282087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.